Back to Search
DANIEL HAMSTRA, MD PHD
MD PHD
Radiation Oncology Physician
NPI: 1386656213IndividualAccepts Medicare
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
4301077751(MI)Q4421(TX)
CMS Specialties
PrimaryRADIATION ONCOLOGY
Education
UNIVERSITY OF MICHIGAN MEDICAL SCHOOL
Class of 2001
Research & Publications (20)
Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neck.
PMID 19043529·Transl Oncol·2008
8-other
Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival.
PMID 18541899·J Clin Oncol·2008
8-other
Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology.
PMID 17827460·J Clin Oncol·2007
6-review
Real-time evaluation of p53 oscillatory behavior in vivo using bioluminescent imaging.
PMID 16885345·Cancer Res·2006
7-preclinical
Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma.
PMID 16267128·Proc Natl Acad Sci U S A·2005
8-other
Intratumoral injection of BCNU in ethanol (DTI-015) results in enhanced delivery to tumor--a pharmacokinetic study.
PMID 15980973·J Neurooncol·2005
4-observational
The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies.
PMID 15509509·Mol Ther·2004
7-preclinical
Expression of endogenously activated secreted or cell surface carboxypeptidase A sensitizes tumor cells to methotrexate-alpha-peptide prodrugs.
PMID 10676650·Cancer Res·2000
8-other
The parametric response map is an imaging biomarker for early cancer treatment outcome.
PMID 19377487·Nat Med·2009
8-other
Inhibition of mTOR radiosensitizes soft tissue sarcoma and tumor vasculature.
PMID 19147764·Clin Cancer Res·2009
7-preclinical
Gemcitabine-mediated radiosensitization of human soft tissue sarcoma.
PMID 18607508·Transl Oncol·2008
8-other
Evaluation of D-methionine as a novel oral radiation protector for prevention of mucositis.
PMID 18381958·Clin Cancer Res·2008
7-preclinical
Radiation therapy reduces local failure and improves overall survival in sPNET.
PMID 18273871·Pediatr Blood Cancer·2008
8-other
Revoking the privilege: targeting HER2 in the central nervous system.
PMID 17981994·Mol Pharmacol·2008
6-review
Noninvasive molecular imaging sheds light on the synergy between 5-fluorouracil and TRAIL/Apo2L for cancer therapy.
PMID 17363540·Clin Cancer Res·2007
7-preclinical
The extent and severity of vascular leakage as evidence of tumor aggressiveness in high-grade gliomas.
PMID 16951209·Cancer Res·2006
8-other
Inhibition of vascular endothelial growth factor (VEGF)-A causes a paradoxical increase in tumor blood flow and up-regulation of VEGF-D.
PMID 16533777·Clin Cancer Res·2006
7-preclinical
Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefit.
PMID 16163381·Gene Ther·2006
7-preclinical
Therapeutic efficacy of DTI-015 using diffusion magnetic resonance imaging as an early surrogate marker.
PMID 15585617·Clin Cancer Res·2004
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 18181 OAKWOOD BLVD
DEARBORN, MI 48124 - Phone
- (313) 593-3733
Quick Facts
- NPI
- 1386656213
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 25
- Publications
- 20
Are you this provider?
Claim Your Profile